New Report Available: Immunocore Limited - Product Pipeline Review - 2013

From: Fast Market Research, Inc.
Published: Thu Sep 05 2013


Global Markets Direct's pharmaceuticals report, "Immunocore Limited - Product Pipeline Review - 2013" provides data on the Immunocore Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Immunocore Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Immunocore Limited and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- http://www.fastmr.com/prod/666650_immunocore_limited_product_pipeline_review_2013.aspx?afid=301

Scope

* Immunocore Limited - Brief Immunocore Limited overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Immunocore Limited human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Immunocore Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Immunocore Limited's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate Immunocore Limited's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Immunocore Limited in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Immunocore Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Immunocore Limited.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Immunocore Limited and identify potential opportunities in those areas.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Alchemia Limited - Product Pipeline Review - 2013
- Progen Pharmaceuticals Limited - Product Pipeline Review - 2013
- CSL Limited - Product Pipeline Review - 2013
- Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2013
- Immunocore Limited - Product Pipeline Review - 2012
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »